MENU
FHTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Foghorn Therapeutics (FHTX) Ownership - Who owns Foghorn Therapeutics?
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system... Show more
Profile
Industry
N/A
Address
500 Technology Square
Phone
+1 617 586-3100
Employees
116
Web
https://www.foghorntx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
273.13M
P/E Ratio
N/A
Total Cash
220.59M
Projected Growth
N/A
Total Debt
34.85M
Revenue
23.5M
Risk (Beta)
3.02
Dividend Yield
N/A
Total Cash/Share
3.96
Total Debt/Equity
N/A
Revenue/Share
0.39 USD as % of share price
Fundamentals
FHTX
Capitalization
273M
P/E Ratio
N/A
Risk (Beta)
3.02
Dividend Yield
N/A
Total Cash
221M
Total Cash/Share
3.96
Total Debt
34.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.39%
Revenue
23.5M
ROE
N/A
Book Value
-61.65M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-1.29
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
3.16
Current Revenue Per Employee
53142.86
Dividends Per Share - Security
N/A
EBITDA
-91.89M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-31.32
Shares Held By Institutions
185M
Shares Outstanding - Current
55.7M
Total Liabilities
320M
Total Volume MTD
N/A
Value
-1
Gain YTD
3.814
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
500 Technology Square
Phone
+1 617 586-3100
Employees
116
Web
https://www.foghorntx.com